Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The pandemic has pushed dermatology education and care to adopt digital solutions, which are effective and likely to continue post-pandemic.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

New drugs for heart disease may be developed from molecules secreted by stem cells.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Scientists found a new, less invasive way to get stem cells from horse hair for veterinary medicine.

Primary cilia affect the size and oil production of eye glands but not the oil's makeup.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

WS Biotin, a new form of D-Biotin, improves water solubility and shows potential for hair and skin care without being toxic at low levels.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Common hair loss disorders may not need stem cell therapy, but could benefit from other treatments like hair cycle control and immune restoration therapy.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

Cannabinoids may help treat various skin conditions.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Trichotillomania was successfully treated with risperidone and naltrexone.